Schizophrenia
Conditions
Interventions
Group A:Risperidone 2-8mg/d, taken once daily for 6 weeks
Group B:Alimentary control for 1-2 days before sampling (low protein, low fat, no eggs, no meat and no milk)
Sponsors
The Second Xiangya Hospital of Central South University
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosis in accordance with (CCMD-III) criteria,With PANSS>=60 or BPRS>=35, were schizophrenia and schizophreniform disorder; 2. Without a history of substance abuse (like alcohol), past or present neurological disease, or any other organic disturbance that might have interfered with the aim of the study; 3. First-episode or neuroleptic-free schizophrenics, with more than 1 month of washout; 4. ages vary from 18-50 years old.
Exclusion criteria
Exclusion criteria: Not accord with the including criteria or shed off during observation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Norepinephrine;gama-aminobutyric acid;5-Hydroxytryptamine;Dopamine;Glutamate; | — |
Secondary
| Measure | Time frame |
|---|---|
| 5-Hydroxytindole-3-acetic acid;3,4-Dihydroxyphenylaceti acid;Homovanillic acid;Vanilmandelic acid;3,4-Dihydroxyphenylaceti acid; | — |
Countries
China
Contacts
Public ContactHuan-De Li
Outcome results
None listed